Nagpur, Maharashtra, India
+919730867604
 Nagpur, Maharashtra, India
+919730867604
+917218129896

Hexabol Trenbolone Injection 76.5mg– Regulatory Overview forFrance, Malaysia, Brazil, Taiwan, Chaina

Hexabol 76.5 mg/ml is an injectable product labeled as containing Trenbolone Hexahydrobenzylcarbonate, a synthetic anabolic-androgenic steroid. The product image displays British Pharma branding and identifies the formulation as an intramuscular injection.

Trenbolone compounds are associated with significant health risks and are subject to strict regulatory restrictions in many countries. Trenbolone Hexahydrobenzylcarbonate is not approved for human medical use in major markets such as the United States.

At BizHQ, we provide pharmaceutical product information, technical specifications, and general regulatory guidance for licensed pharmaceutical professionals, distributors, and authorized organizations.

Hexabol 76.5 mg/ml Product Details

Product SpecificationDetails
Brand NameHexabol
Generic NameTrenbolone Hexahydrobenzylcarbonate
Strength76.5 mg/ml
Dosage FormInjectable Oil-Based Solution
Vial Size10 ml
Packaging TypeMultidose Glass Vial
Route IndicatedIntramuscular (IM)
Brand MarkingBritish Pharma
Product CategoryAnabolic-Androgenic Steroid
Label StatusRx Only
Regulatory ClassificationControlled or restricted in many countries

These details are based on the supplied packaging image. Product authenticity, composition, manufacturer identity, and regulatory approval have not been independently verified.

What Is Trenbolone Hexahydrobenzylcarbonate?

Trenbolone Hexahydrobenzylcarbonate is a long-acting ester of trenbolone, a potent synthetic anabolic-androgenic steroid.

Trenbolone derivatives have a history of veterinary and experimental use. However, Hexabol should not be assumed to be an approved human medicine simply because its packaging displays prescription labeling.

The substance can cause serious cardiovascular, hormonal, reproductive, and psychological adverse effects.

Product Packaging Information

The supplied Hexabol packaging shows:

  • 10 ml multidose vial

  • 76.5 mg/ml labeled concentration

  • Orange vial cap

  • British Pharma branding

  • Intramuscular-use labeling

  • Prescription-only marking

Actual product specifications and quality should be confirmed through independently verified manufacturer documentation and laboratory testing.

International Regulatory Information

Regulatory restrictions for trenbolone products differ between countries.

In the USA, trenbolone is classified as an anabolic steroid under federal controlled-substance law, and Trenbolone Hexahydrobenzylcarbonate is not FDA-approved for human treatment.

In markets such as the UK, Canada, Australia, Germany, France, UAE, and Saudi Arabia, relevant controlled-substance, pharmaceutical, and importation requirements must be assessed individually.

A product's inclusion in an online catalogue does not establish its legal availability, registration, or authorization for importation.

Important Safety Information

Trenbolone exposure may be associated with serious adverse effects, including:

  • Cardiovascular complications

  • Adverse cholesterol changes

  • Suppression of natural testosterone production

  • Fertility and reproductive problems

  • Mood and behavioral changes

  • Other hormonal complications

The product should not be used for bodybuilding, performance enhancement, or self-medication.

Frequently Asked Questions

1. What is Hexabol 76.5 mg/ml?

Hexabol is labeled as an injectable formulation containing Trenbolone Hexahydrobenzylcarbonate at a concentration of 76.5 mg/ml.

2. What is the vial size?

The supplied packaging indicates a 10 ml multidose vial.

3. Is Hexabol approved for human use?

Human-use approval should not be assumed. Trenbolone Hexahydrobenzylcarbonate is not FDA-approved for human medical treatment in the United States.

4. Is Trenbolone Hexahydrobenzylcarbonate a controlled substance?

Trenbolone is controlled or restricted in numerous jurisdictions. Specific legal requirements depend on the country.

5. What documentation is relevant to pharmaceutical regulatory assessment?

Relevant documentation may include manufacturer licenses, product registration evidence, certificates of analysis, quality records, and applicable controlled-substance authorizations.

Contact BizHQ – Pharmaceutical Information

For general pharmaceutical product information, regulatory documentation, and professional business correspondence, contact:

Company Name: BizHQ
Website: https://medicineindiaexport.com
WhatsApp / Contact Number: +91 9209725630

 2026-11-18T07:07:04

Keywords